Paratus Diagnostics
Rob Donnelly is an investor and entrepreneur with 18 years of investment management, biotechnology, and corporate board experience. His former roles include principal investing and executive management across a diverse range of emerging companies.
In 1999, Rob was a founding principal of Genesis Park, Houston-based venture capital and private equity fund that invested across industries and structures. His experience in venture includes life sciences, material sciences, and software; while his private equity interests cover buy-out, turn-around, and value-add opportunities. Rob earned a B.S. in Biomedical Science from Texas A&M University and an M.B.A. in Finance from Southern Methodist University.
This person is not in any offices
Paratus Diagnostics
Paratus Diagnostics is a clinical laboratory and biotechnology company that is advancing the field of molecular testing and transforming point-of-care diagnostics. As a high-complexity CLIA certified lab, they provide critical and time sensitive diagnostic testing solutions to healthcare providers and patients across the United States. Developing accurate, efficient, and patient-friendly salivary tests is a core advantage. The clinical lab, located in Central Texas, serves a broad customer base with quality, timely, and cost-effective results.